C-type natriuretic peptide in Parkinson’s disease: reduced secretion and response to deprenyl

Author： Espiner E.   Dalrymple-Alford J.   Prickett T.   Alamri Y.   Anderson T.  

Publisher： Springer Publishing Company

ISSN： 0300-9564

Source： Journal of Neural Transmission, Vol.121, Iss.4, 2014-04, pp. : 371-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Melatonin in Parkinson's disease

By Medeiros C.  

Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. : 759-759

Springer Publishing Company

Access to resources Recommend Favorite

A vaccine for Parkinson’s disease?

By Chesselet Marie-Francoise  

Future Neurology, Vol. 1, Iss. 1, 2006-01 ,pp. : 21-23

Future Medicine

Access to resources Recommend Favorite

Pathophysiology of Parkinson’s disease

By Mandir Allen S.   Vaughan Christina  

International Review of Psychiatry, Vol. 12, Iss. 4, 2000-11 ,pp. : 270-280

Informa Healthcare

Access to resources Recommend Favorite

Effects of stimulus-response compatibility in Parkinson’s disease: a psychophysiological analysis

By Falkenstein M.   Willemssen R.   Hohnsbein J.   Hielscher H.  

Journal of Neural Transmission, Vol. 113, Iss. 10, 2006-10 ,pp. : 1449-1462

Springer Publishing Company

Access to resources Recommend Favorite

Orienting of attention and Parkinson’s disease: tactile inhibition of return and response inhibition

By Poliakoff E.  

Brain, Vol. 126, Iss. 9, 2003-09 ,pp. : 2081-2092

Oxford University Press

Access to resources Recommend Favorite